We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

On Monday, Denali Therapeutics Inc (DNLI) stock saw a modest uptick, ending the day at $27.78 which represents a slight increase of $1.63 or 6.23% from the prior close of $26.15. The stock opened at ...

In a report released today, Michael Yee from Jefferies maintained a Buy rating on Denali Therapeutics (DNLI – Research Report), with a ...

On Friday, Denali Therapeutics Inc (DNLI) stock saw a modest uptick, ending the day at $27.05 which represents a slight increase of $1.09 or 4.20% from the prior close of $25.96. The stock opened at ...

Denali Therapeutics Inc (NASDAQ:DNLI) shares are moving lower in Thursday’s after-hours session after the company announced ...

Jefferies raised the firm’s price target on Denali Therapeutics (DNLI) to $45 from $40 and keeps a Buy rating on the shares ahead of the company reporting first DNL-126 Phase 1/2 data in ...

Federal highway officials on Thursday announced $635 million to repair or replace numerous old and outdated bridges ranging from Alaska to Maine, including a couple located in popular national parks.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Denali Therapeutics announces its Phase 2 study of oditrasertib was discontinued. Denali's strategic partner says the study failed to meet the primary and key secondary endpoints. Denali ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

Morgan Stanley (NYSE:MS) analyst Matthew Harrison maintained a Buy rating on Denali Therapeutics (NASDAQ:DNLI) Inc on Monday, setting a price target of $45, which is... H.C. Wainwright analyst ...